DRUGART

DRUGART
Product Description

A proprietary AI-biological intelligence platform that integrates computational models, proprietary biological data and experimental validation into a continuously learning discovery engine for drugs, biologics, enzymes and diagnostics.

CapeBio

  • Country/Region:
    South Africa
  • On CPHI since:
    2026
  • Certificates:
    2
  • Employees:
    1 - 24
Company types
Manufacturer/Innovator
Primary activities
Medical Devices
Medical Technologies
Specifications
  • Details
    DRUGART is a platform that leverages African microbial datasets (metagenomes) to discover novel healthcare biomolecules (enzymes, proteins, peptides and compounds). The platform converges computational models, proprietary biological data and experimental validation into a continuously learning discovery engine for drugs, biologics, enzymes and diagnostics. The current iteration supports research and development and is being tested for drug discovery and clinical optimisation. 

CapeBio

  • Country/Region:
    South Africa
  • On CPHI since:
    2026
  • Certificates:
    2
  • Employees:
    1 - 24
Company types
Manufacturer/Innovator
Primary activities
Medical Devices
Medical Technologies

More Products from CapeBio (2)

  • Capebio Supermix Platform

    Product Capebio Supermix Platform

    One-Step varieties for fast detection of infectious pathogens. 
  • DNA/RNA synthesis services

    Product DNA/RNA synthesis services

    rimers and hydrolysis probes - scale depends on the client's needsRNA molecules - up to 2 mg/mlDNA molecules - up to 500bp